Management of patients with severe Epstein syndrome: Review of four patients who received living‐donor renal transplantation

Nephrology ◽  
2019 ◽  
Vol 24 (4) ◽  
pp. 450-455 ◽  
Author(s):  
Junya Hashimoto ◽  
Yuko Hamasaki ◽  
Yusuke Takahashi ◽  
Mai Kubota ◽  
Taketo Yanagisawa ◽  
...  



2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i313-i314
Author(s):  
Jin Hae Kim ◽  
Do Hee Kim ◽  
Jee Eun Park ◽  
Hye Ryoun Jang ◽  
Jung Eun Lee ◽  
...  


1990 ◽  
Vol 49 (1) ◽  
pp. 25-29 ◽  
Author(s):  
FRED SANFILIPPO ◽  
LEROY THACKER ◽  
WILLIAM K. VAUGHN


2011 ◽  
Vol 43 (6) ◽  
pp. 2418-2420 ◽  
Author(s):  
K. Sakai ◽  
M. Okamoto ◽  
K. Koshino ◽  
T. Suzuki ◽  
S. Nobori ◽  
...  


2016 ◽  
Vol 103 (9) ◽  
pp. 1230-1236 ◽  
Author(s):  
J. Nath ◽  
J. Hodson ◽  
S. W. Canbilen ◽  
J. Al Shakarchi ◽  
N. G. Inston ◽  
...  


1992 ◽  
Vol 2 (12) ◽  
pp. S228
Author(s):  
J S Najarian ◽  
P S Almond ◽  
M Mauer ◽  
B Chavers ◽  
T Nevins ◽  
...  

The treatment of choice for end-stage renal failure within the first year of life is controversial. Between September 1970 and February 1991, we performed 28 kidney transplants (27 primary, 1 retransplant, 23 living donor, 5 cadaver) in infants less than 1 yr of age (mean, 7 +/- 2 months; range, 6 wk to 12 months). The 1-yr patient survival rate for living donor recipients was 100% versus 20% for cadaver recipients (P = 0.0001). The 1-yr graft survival rate for living donor recipients was 96% versus 20% for cadaver recipients (P = 0.001). The 1-yr patient survival rate for cyclosporin A (CSA) recipients (N = 12) was 100% versus 75% for non-CSA recipients (P = 0.03). The 1-yr graft survival rate for CSA recipients was 92% versus 75% for non-CSA recipients (P = 0.08). There was no difference in the number of rejection episodes or serum creatinine levels in CSA versus non-CSA recipients. Compared with pretransplant values, the mean posttransplant standard deviation scores (SDS) for height (N = 18), weight (N = 22), and head circumference (N = 8) improved: height SDS from -1.9 to -1.5 (not significant); weight SDS from -2.5 to 0.6 (P less than 0.0005); head circumference SDS from -2.0 to -0.7 (P = 0.01). Because no other renal replacement therapy can match these results, we conclude that renal transplantation is the treatment of choice for infants with end-stage renal failure.



PLoS ONE ◽  
2018 ◽  
Vol 13 (7) ◽  
pp. e0199629 ◽  
Author(s):  
Shigeyoshi Yamanaga ◽  
Angel Rosario ◽  
Danny Fernandez ◽  
Takaaki Kobayashi ◽  
Mehdi Tavakol ◽  
...  


2013 ◽  
Vol 27 (6) ◽  
pp. 838-843 ◽  
Author(s):  
Ioannis D. Kostakis ◽  
Demetrios N. Moris ◽  
Alexandros Barlas ◽  
Ioannis Bokos ◽  
Maria Darema ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document